Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

3D Medicines Inc.

https://en.3d-medicines.com/

Latest From 3D Medicines Inc.

H1 Winners And Laggards In China's Sizzling Home-Grown IO market

Four latecomers including Akeso and Henlius managed to record a combined $101m in immuno-oncology drug sales in China in the first half, while market leaders such as BeiGene and Innovent saw mixed results as competition between domestically-developed rivals continues to heat up.

China ImmunoOncology

Great Leap: Major Chinese Pharmas See Innovative Drug Sales Breakthrough in H1

A number of major Chinese pharma firms, including Simcere and Hansoh, brought in more revenues from innovative drugs than generics in the first half, a major stand-out from their domestic peers.

China Sales & Earnings

Too Crowded? ImmuneOncia Looks To Niches To Challenge PD-L1 Space

ImmuneOncia CEO talks to Scrip about the development strategy for its anti-PD-L1 and anti-CD47 pipeline assets as well as the advantages of having Yuhan and Sorrento as its largest shareholders.

South Korea ImmunoOncology

AZ, Junshi Part Ways Amid China IO Commercial Struggle

Multinationals including AstraZeneca are retreating from China’s overcrowded immuno-oncology market but one exception - Pfizer - remains steadfast.

China Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • 3DMed
    • 3D Medicines (Sichuan) Co., Ltd.
    • 3D Medicines (Beijing) Co., Ltd.
UsernamePublicRestriction

Register